Literature DB >> 17704826

Endocannabinoids and the haematological system.

M D Randall1.   

Abstract

Endocannabinoids are blood borne and may also be secreted by the endothelium. Accordingly, there has been interest in the interactions between (endo)cannabinoids and blood cells. There is certainly evidence that (endo)cannabinoids may promote platelet activation, indicating that they may be thrombogenic. Platelets are involved both in the metabolism and release of endocannabinoids, and so it is possible that their circulating levels may be regulated by platelets. This process is altered in disease states such that platelet-derived endocannabinoids contribute towards hypotension in cardiovascular shock. Not only may endocannabinoids regulate platelet function and possibly lead to thrombogenesis, but they may also influence haematopoiesis. Given these emerging roles, the aim of this review is to examine the interactions between cannabinoids and blood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704826      PMCID: PMC2190025          DOI: 10.1038/sj.bjp.0707420

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells.

Authors:  E V Berdyshev; P C Schmid; R J Krebsbach; H H Schmid
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

3.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

4.  Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.

Authors:  M Maccarrone; L De Petrocellis; M Bari; F Fezza; S Salvati; V Di Marzo; A Finazzi-Agrò
Journal:  Arch Biochem Biophys       Date:  2001-09-15       Impact factor: 4.013

5.  Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol.

Authors:  Meritxell Alberich Jordà; Sandra E Verbakel; Peter J M Valk; Yolanda V Vankan-Berkhoudt; Mauro Maccarrone; Allessandro Finazzi-Agrò; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid.

Authors:  S Braud; C Bon; L Touqui; C Mounier
Journal:  FEBS Lett       Date:  2000-04-07       Impact factor: 4.124

7.  The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets.

Authors:  Engelbert Deusch; Hans Georg Kress; Birgit Kraft; Sibylle A Kozek-Langenecker
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

8.  Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors.

Authors:  S Akerman; H Kaube; P J Goadsby
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

9.  Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation.

Authors:  Mauro Maccarrone; Monica Bari; Natalia Battista; Alessandro Finazzi-Agrò
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

10.  The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.

Authors:  Meritxell Alberich Jordà; Nazik Rayman; Marjolein Tas; Sandra E Verbakel; Natalia Battista; Kirsten van Lom; Bob Löwenberg; Mauro Maccarrone; Ruud Delwel
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113

View more
  13 in total

1.  Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.

Authors:  X Zhang; Y Maor; J F Wang; G Kunos; J E Groopman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Cannabinoids and their actions.

Authors:  S P H Alexander; M Randall
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

3.  Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.

Authors:  Shuxian Jiang; Meritxell Alberich-Jorda; Radoslaw Zagozdzon; Kalindi Parmar; Yigong Fu; Peter Mauch; Naheed Banu; Alexandros Makriyannis; Daniel G Tenen; Shalom Avraham; Jerome E Groopman; Hava Karsenty Avraham
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

4.  Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.

Authors:  Matthew N Hill; Gregory E Miller; Erica J Carrier; Boris B Gorzalka; Cecilia J Hillard
Journal:  Psychoneuroendocrinology       Date:  2009-04-25       Impact factor: 4.905

5.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters.

Authors:  JodiAnne T Wood; John S Williams; Lakshmipathi Pandarinathan; Amber Courville; Melissa R Keplinger; David R Janero; Paul Vouros; Alexandros Makriyannis; Carol J Lammi-Keefe
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

Review 6.  Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations.

Authors:  Pál Pacher; Partha Mukhopadhyay; Rajesh Mohanraj; Grzegorz Godlewski; Sándor Bátkai; George Kunos
Journal:  Hypertension       Date:  2008-09-08       Impact factor: 10.190

7.  Recurrent STEMI Precipitated by Marijuana Use: Case Report and Literature Review.

Authors:  Perry Wengrofsky; Ghassan Mubarak; Ahmed Shim; Pramod Theetha Kariyanna; Adam Buzidkowski; Jacob Schwartz; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018

8.  Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.

Authors:  Antje Scholl; Igor Ivanov; Burkhard Hinz
Journal:  Oncotarget       Date:  2016-09-20

Review 9.  Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.

Authors:  Natasha Irrera; Alessandra Bitto; Emanuela Sant'Antonio; Rita Lauro; Caterina Musolino; Alessandro Allegra
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

10.  Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain.

Authors:  Carmen La Porta; S Andreea Bura; Jone Llorente-Onaindia; Antoni Pastor; Francisco Navarrete; María Salud García-Gutiérrez; Rafael De la Torre; Jorge Manzanares; Jordi Monfort; Rafael Maldonado
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.